The abstract is read at the publisher; the summary is JClub's.
MC1R loss-of-function variants are linked to accelerated motor decline in Parkinson disease, with carriers showing 30% faster decline in PPMI sporadic PD and 50% faster in replication.
- Why it matters: Progression markers that reliably predict worsening in Parkinson disease are needed to improve prognosis and to enrich clinical trials for higher-risk genetic subgroups.
- What they did: In a longitudinal cohort study using PPMI (809 participants) and a replication set from three US multicenter trials (587 participants), investigators modeled motor decline with linear mixed-effects models and assessed phenoconversion with Fine-Gray hazards.
- The result: In PPMI sporadic PD, carriers had a slope of 0.57 points/year versus noncarriers, and in replication carriers had a slope of 1.37; in prodromal PD, carriers had a phenoconversion subdistribution hazard ratio of 4.75.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.